Atossa Therapeutics (ATOS) Depreciation and Depletion (2012 - 2026)
Atossa Therapeutics (ATOS) reported Depreciation and Depletion of $4,000 for Q2 2026, unchanged from $4,000 a year earlier and unchanged from the prior quarter.
Atossa Therapeutics (ATOS) Depreciation and Depletion (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Atossa Therapeutics' Depreciation and Depletion came in at $16,000, unchanged year-over-year; for FY2025, it came in at $16,000, down 5.9% from FY2024.
- Depreciation and Depletion has a five-year compound annual growth rate of -3.4% (FY2020 to FY2025).
- By year, Depreciation and Depletion came in at $17,000 in FY2024 (-26.1%), $23,000 in FY2023 (+187.5%), $8,000 in FY2022 (-20.0%) and $10,000 in FY2021 (-47.4%).
- Five-year quarterly Depreciation and Depletion spans a low of $3,000 in Q1 2023 and a high of $14,000 in Q4 2023.
- Year over year, Depreciation and Depletion gained in 1 of the last eight quarters, with an average decline of 7.3%.
- The high point for year-over-year Depreciation and Depletion in five years was Q1 2024 (growth of 66.7%); the low point was Q4 2024 (a decline of 71.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4,000 (Q1 2026), $4,000 (Q4 2025) and $4,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Atossa Therapeutics | 21.38 Mn | -98.31 Mn | - | 4,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4,000.00 |
| Jun 30, 2026 | 4,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Mar 31, 2018 | 2,725.00 |
| Dec 31, 2017 | 2,968.00 |
| Sep 30, 2017 | 4,554.00 |
| Jun 30, 2017 | 8,773.00 |
| Mar 31, 2017 | 9,662.00 |
Atossa Therapeutics Depreciation and Depletion API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ATOS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-depletion", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();